Matthias Bodenstedt insider trades
Open-market stock purchases and sales by Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics, from SEC Form 4 filings since Apr 5, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +97%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $862K |
| Jun 18, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $54.8K |
| Jun 17, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $297K |
| May 11, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $273K |
| Apr 14, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $47.5K |
| Apr 10, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $37.6K |
| Apr 9, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $1.6M |
| Jan 7, 2026 | MLTX MoonLake Immunotherapeutics | Bought (not open market) | — |
| Dec 19, 2025 | MLTX MoonLake Immunotherapeutics | Bought (not open market) | — |
| Dec 19, 2025 | MLTX MoonLake Immunotherapeutics | Sold (not open market) | — |
| Dec 19, 2025 | MLTX MoonLake Immunotherapeutics | Bought (not open market) | — |
| Oct 8, 2025 | MLTX MoonLake Immunotherapeutics | Bought | $98.8K |
Companies traded
- MLTX MoonLake Immunotherapeutics: 1 buy, 9 sales, last Jun 22, 2026
Get free alerts when Matthias Bodenstedt files a new trade →